[1]
Mousa, M.J. et al. 2025. Serum CA 19-9 as a potential biomarker for diabetic neuropathy: a comparative study among diabetic patients and healthy controls. Pharmakeftiki . 37, 2S (Oct. 2025). DOI:https://doi.org/10.60988/p.v37i2S.227.